USANA enters $75M revolving credit facility with Bank of America, $200M accordion option

USANA HEALTH SCIENCES INC

New $75M revolver replaces prior agreement; includes $200M accordion feature subject to conditions.
Interest on Term SOFR loans at Term SOFR plus 1.75%; commitment fee 0.25%.
Financial covenants: minimum consolidated EBITDA of $80M (step-up to $100M after Q3 2026) and funded debt/EBITDA ≤ 2.0x.
No restrictions on cash dividends or share repurchases under the credit agreement.
Obligations secured by pledge of capital stock of subsidiaries via Amended and Restated Security and Pledge Agreement.

item 1.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.